Quick Answer
BIOTRICITY INC. reported Research And Development Expense of $2.16 million for the year ending 2025.
- BIOTRICITY INC. showed a decrease of -16.2% in Research And Development Expense from 2024 to 2025.
- This data is from BIOTRICITY INC.'s annual report (Form 10-K), filed with the SEC on July 15, 2025.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), BIOTRICITY INC.'s Research And Development Expense has grown by 88.5%.
- Historical annual values: Fiscal year 2025: $2.16 million | Fiscal year 2024: $2.57 million | Fiscal year 2023: $3.23 million | Fiscal year 2022: $2.74 million | Fiscal year 2021: $2.06 million | Fiscal year 2020: $1.36 million | Fiscal year 2019: $1.31 million | Fiscal year 2018: $1.76 million | Fiscal year 2017: $1.14 million | Fiscal year 2016: $1.09 million | Fiscal year 2015: $1.14 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: